We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
-5.32%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$167M
AUM Growth
-$394M
Cap. Flow
-$366M
Cap. Flow %
-218.91%
Top 10 Hldgs %
44.66%
Holding
98
New
19
Increased
–
Reduced
39
Closed
38

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$4.56M
2
WBA
Walgreens Boots Alliance
WBA
+$2.89M
3
AGN
Allergan plc
AGN
+$2.59M
4
AAAP
Advanced Accelerator Applications S.A.
AAAP
+$2.02M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.9M

Top Sells

Rank Stock Value
1
CLVS
Clovis Oncology, Inc.
CLVS
+$20.2M
2
RARE icon
Ultragenyx Pharmaceutical
RARE
+$17M
3
PFE icon
Pfizer
PFE
+$16.9M
4
ZBH icon
Zimmer Biomet
ZBH
+$13.2M
5
SHPG
Shire pic
SHPG
+$12.6M

Sector Composition

Rank Sector Weight
1 Healthcare 75.65%
2 Energy 0.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GBT
26
DELISTED
Global Blood Therapeutics, Inc.
GBT
$2.53M 1.51%
175,000
-475,000
-73% -$8.35M
SUPN icon
27
Supernus Pharmaceuticals
SUPN
$2.73B
$2.52M 1.51%
100,000
-200,000
-67% -$4.47M
TVTY
28
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$2.27M 1.36%
100,000
-230,000
-70% -$5.41M
WBA
29
CALL
DELISTED
Walgreens Boots Alliance
WBA
$2.07M 1.24%
+25,000
New +$2.07M
CCXI
30
DELISTED
ChemoCentryx, Inc.
CCXI
$2M 1.19%
270,000
-30,000
-10% -$216K
REGN icon
31
Regeneron Pharmaceuticals
REGN
$82.1B
$1.84M 1.1%
+5,001
New +$1.9M
GILD icon
32
Gilead Sciences
GILD
$168B
$1.79M 1.07%
25,000
-95,000
-79% -$7.06M
NERV icon
33
Minerva Neurosciences
NERV
$206M
$1.76M 1.05%
18,750
-37,500
-67% -$3.83M
AAAP
34
DELISTED
Advanced Accelerator Applications S.A.
AAAP
$1.61M 0.96%
+60,000
New +$2.02M
XLRN
35
DELISTED
Acceleron Pharma
XLRN
$1.53M 0.92%
60,000
-10,000
-14% -$317K
VTRS icon
36
Viatris
VTRS
$18.7B
$1.53M 0.91%
+40,000
New +$1.49M
BSX icon
37
Boston Scientific
BSX
$74.2B
$1.41M 0.84%
65,000
-35,000
-35% -$764K
LHCG
38
DELISTED
LHC Group LLC
LHCG
$1.37M 0.82%
30,000
-100,000
-77% -$4.07M
AZN icon
39
CALL
AstraZeneca
AZN
$246B
$1.37M 0.82%
+25,000
New +$1.42M
AZN icon
40
AstraZeneca
AZN
$246B
$1.37M 0.82%
+25,000
New +$1.42M
ACRS icon
41
Aclaris Therapeutics
ACRS
$871M
$1.36M 0.81%
+50,000
New +$1.27M
DXCM icon
42
DexCom
DXCM
$33.8B
$1.19M 0.71%
+80,000
New +$1.42M
IMMU
43
DELISTED
Immunomedics Inc
IMMU
$1.1M 0.66%
300,000
-300,000
-50% -$888K
XENT
44
DELISTED
Intersect ENT, Inc
XENT
$908K 0.54%
75,000
-105,000
-58% -$1.36M
XNTK icon
45
CALL
State Street SPDR NYSE Technology ETF
XNTK
$2.22B
$888K 0.53%
+15,000
New +$902K
ARRY
46
DELISTED
Array Biopharma Inc
ARRY
$879K 0.53%
100,000
-300,000
-75% -$2.21M
HZNP
47
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$809K 0.48%
+50,000
New +$907K
SCYX icon
48
SCYNEXIS
SCYX
$48M
$798K 0.48%
3,125
– –
RARX
49
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$760K 0.45%
+50,000
New +$680K
AKAO
50
DELISTED
Achaogen Inc
AKAO
$651K 0.39%
+50,000
New +$343K
1
2
3 4

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q4 2016 Portfolio in Review

As of Q4 2016, Iguana Healthcare Management held 98 positions worth $167M, down 70% from $561M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Iguana Healthcare Management withdrew a net $366M in Q4 2016, closing 38 positions and reducing 39 holdings. Its most notable exit was Pfizer, an estimated $16.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, up from 73% a quarter earlier, followed by Energy.

Against the trend, Iguana Healthcare Management opened a new position in Abbott worth $4.42M.

  • Iguana Healthcare Management's largest Q4 2016 buy was Abbott: 115,000 shares worth $4.42M.
  • Iguana Healthcare Management's biggest Q4 2016 reduction was Clovis Oncology, Inc., cutting an estimated $20.2M.
  • Iguana Healthcare Management fully exited Pfizer in Q4 2016, selling an estimated $16.9M.
  • Iguana Healthcare Management's ten largest holdings make up 45% of its $167M portfolio in Q4 2016.
  • Iguana Healthcare Management opened 19 new positions and closed 38 in Q4 2016.
  • Iguana Healthcare Management's portfolio value fell 70% quarter-over-quarter to $167M.

Based on Iguana Healthcare Management's 13F filing for Q4 2016, filed 14 Feb 2017.